BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
91 hedge funds and large institutions have $154M invested in Bellicum Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
28% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 32
Holders
91
Holding in Top 10
–
Calls
$1.18M
Puts
$1.6M
Top Buyers
| 1 | +$1.25M | |
| 2 | +$1.04M | |
| 3 | +$639K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$498K |
| 5 |
VFA
Virtus Fund Advisers
Hartford,
Connecticut
|
+$343K |
Top Sellers
| 1 | -$4.72M | |
| 2 | -$989K | |
| 3 | -$922K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$856K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$668K |